Adults who use the prescription drug metformin to treat their type 2 diabetes have a lower risk of developing long COVID or dying after a COVID-19 infection than people with diabetes who take other anti-diabetes medications, according to a recent large study. The findings, published in the journal Diabetes Care, were based on health data from millions of U.S. patients and could have broader implications for the use of metformin in long COVID prevention generally.
This article was originally published on MedicalXpress.com
